This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ tripelennamine hydrochloride,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Allergic Rhinitis:

    • Symptom Relief: Tripelennamine hydrochloride helps alleviate symptoms of allergic rhinitis, including sneezing, itching, watery eyes, and runny nose, by blocking the effects of histamine.

  2. Allergic Conjunctivitis:

    • Eye Symptom Relief: Tripelennamine hydrochloride may be used to relieve symptoms of allergic conjunctivitis, such as itching, redness, and watering of the eyes.

  3. Urticaria (Hives):

    • Symptom Relief: Tripelennamine hydrochloride can help alleviate symptoms of urticaria, including itching, swelling, and redness of the skin, by blocking the actions of histamine.

  4. Allergic Dermatitis:

    • Itch Relief: Tripelennamine hydrochloride may be used to relieve itching associated with allergic dermatitis, such as insect bites, contact dermatitis, or other skin allergies.

  5. Motion Sickness:

    • Antiemetic Effects: Tripelennamine hydrochloride has antiemetic properties and may be used to prevent or alleviate symptoms of motion sickness, such as nausea and vomiting, by acting on the central nervous system.

  6. Sedation:

    • Drowsiness: One of the common side effects of tripelennamine hydrochloride is sedation or drowsiness. It can cause drowsiness and impair cognitive and motor function, so caution should be exercised when driving or operating machinery.

  7. Adverse Effects:

    • Dry Mouth: Tripelennamine hydrochloride may cause dry mouth as a side effect.
    • Urinary Retention: In some cases, tripelennamine hydrochloride may lead to urinary retention, especially in individuals with prostate enlargement or other urinary tract issues.
    • Other Side Effects: Less common side effects may include dizziness, blurred vision, constipation, and gastrointestinal disturbances.

  8. Avoidance:

    • Drug Interactions: Tripelennamine hydrochloride may interact with other medications, including central nervous system depressants such as alcohol, benzodiazepines, and opioids, leading to increased sedation and respiratory depression.

  9. Precautions:

    • Children and Elderly: Tripelennamine hydrochloride should be used with caution in children and elderly individuals, as they may be more sensitive to its sedative effects.
    • Pregnancy and Lactation: The safety of tripelennamine hydrochloride during pregnancy and lactation has not been established, so it should be used with caution or avoided in pregnant or breastfeeding women.
;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of tripelennamine hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Reduces
species Lacticaseibacillus paracasei Reduces
species Parabacteroides distasonis Reduces

Bacteria Impacted by tripelennamine hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Roseburia genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Ruminococcus genus Decreases
1 0 Akkermansia genus Decreases
0 1 Enterocloster genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
1 0 Ruminococcus bromii species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
1 0 Enterocloster bolteae species Decreases
1 0 Roseburia intestinalis species Decreases
0 1 Akkermansia glycaniphila species Decreases
1 0 Parabacteroides distasonis species Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases

Impact of tripelennamine hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 1.3 1.3
Age-Related Macular Degeneration and Glaucoma 0.5 0.4 0.25
Allergic Rhinitis (Hay Fever) 0.4 0.3 0.33
Allergies 1.2 1.7 -0.42
Allergy to milk products 0.9 0.4 1.25
Alopecia (Hair Loss) 0 0
Alzheimer's disease 2.1 1 1.1
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.8 1.4 -0.75
Ankylosing spondylitis 0.3 0.3 0
Anorexia Nervosa 0.7 0.8 -0.14
Antiphospholipid syndrome (APS) 0.1 0.1
Asthma 0.5 1.4 -1.8
Atherosclerosis 0.3 0.9 -2
Atrial fibrillation 0.7 0.4 0.75
Autism 2.3 2.1 0.1
Autoimmune Disease 0.5 -0.5
Bipolar Disorder 0.7 0.8 -0.14
Brain Trauma 0.8 -0.8
Breast Cancer 0.3 -0.3
Cancer (General) 0.6 -0.6
Carcinoma 0.7 0.7 0
Celiac Disease 0.1 1 -9
Cerebral Palsy 0.3 0.8 -1.67
Chronic Fatigue Syndrome 1.1 0.3 2.67
Chronic Kidney Disease 0.4 0.8 -1
Chronic Lyme 0.5 -0.5
Chronic Obstructive Pulmonary Disease (COPD) 0.5 -0.5
Chronic Urticaria (Hives) 0.6 -0.6
Coagulation / Micro clot triggering bacteria 0.4 0.8 -1
Cognitive Function 1.3 0.5 1.6
Colorectal Cancer 2.7 1.1 1.45
Constipation 0.3 1.4 -3.67
Coronary artery disease 0.3 0.5 -0.67
COVID-19 1.3 2.4 -0.85
Crohn's Disease 1.6 2.1 -0.31
cystic fibrosis 0.5 -0.5
deep vein thrombosis 1.1 0.8 0.38
Depression 2.9 3.4 -0.17
Endometriosis 0.4 0.8 -1
Epilepsy 0.3 1.3 -3.33
Fibromyalgia 1 1 0
Functional constipation / chronic idiopathic constipation 0.8 1.3 -0.63
gallstone disease (gsd) 0.7 0.8 -0.14
Generalized anxiety disorder 0.3 0.8 -1.67
Gout 0.6 0.6 0
Graves' disease 0.7 0.8 -0.14
Gulf War Syndrome 0.8 -0.8
Hashimoto's thyroiditis 1.1 0.3 2.67
Heart Failure 0.7 1.1 -0.57
hemorrhagic stroke 0.4 0.4
High Histamine/low DAO 0.5 0.3 0.67
hypercholesterolemia (High Cholesterol) 0.6 -0.6
hyperglycemia 0.6 1.3 -1.17
Hyperlipidemia (High Blood Fats) 0.3 0.3
hypertension (High Blood Pressure 1.6 1.1 0.45
Hypothyroidism 0.3 0.3
Hypoxia 0.7 0.7
IgA nephropathy (IgAN) 0.7 0.5 0.4
Inflammatory Bowel Disease 0.7 2.4 -2.43
Insomnia 0.3 1.7 -4.67
Intracranial aneurysms 0.7 0.7
Irritable Bowel Syndrome 1.7 2.1 -0.24
ischemic stroke 1 0.5 1
Liver Cirrhosis 1.6 2.3 -0.44
Long COVID 0.9 2.2 -1.44
Low bone mineral density 0.5 -0.5
Lung Cancer 0.9 -0.9
Mast Cell Issues / mastitis 0.3 -0.3
ME/CFS with IBS 0.2 0.2
ME/CFS without IBS 0 0
Menopause 0.8 -0.8
Metabolic Syndrome 1.6 2.1 -0.31
Mood Disorders 3.5 2.7 0.3
multiple chemical sensitivity [MCS] 0.3 0.3
Multiple Sclerosis 1.6 1.3 0.23
Multiple system atrophy (MSA) 0.8 0.3 1.67
myasthenia gravis 0.5 -0.5
neuropathic pain 1.3 -1.3
Neuropathy (all types) 0.3 1 -2.33
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.8 1.7 -1.13
NonCeliac Gluten Sensitivity 0.6 0.6
Obesity 2.7 3.3 -0.22
obsessive-compulsive disorder 1 0.6 0.67
Osteoarthritis 0.6 -0.6
Osteoporosis 0.8 0.6 0.33
Parkinson's Disease 3 1.8 0.67
Polycystic ovary syndrome 1.9 1.7 0.12
Premenstrual dysphoric disorder 0.4 -0.4
Primary sclerosing cholangitis 0.4 0.7 -0.75
Psoriasis 0.6 1.6 -1.67
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.2 0.5 3.4
Rosacea 0.3 0.5 -0.67
Schizophrenia 1.3 1.6 -0.23
scoliosis 0.3 -0.3
Sjögren syndrome 0.4 0.4 0
Sleep Apnea 0.3 0.8 -1.67
Slow gastric motility / Gastroparesis 0.3 0.3
Stress / posttraumatic stress disorder 1.3 1.5 -0.15
Systemic Lupus Erythematosus 0.4 0.8 -1
Tic Disorder 0.3 0.3
Tourette syndrome 0.3 0.3
Type 1 Diabetes 0.9 0.9 0
Type 2 Diabetes 1.7 2.1 -0.24
Ulcerative colitis 0.4 2.2 -4.5
Unhealthy Ageing 0.2 1.3 -5.5
Vitiligo 0.7 0.7 0

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]